Plerixafor salvage is safe and effective in hard-to-mobilize patients undergoing chemotherapy and filgrastim-based peripheral blood progenitor cell mobilization

Journal of Oncology

Volumn , Issue , 2012, Pages

  Awan, Farrukh T ^a   Kochuparambil, S Thomas ^a   Deremer, David ^a   Cumpston, Aaron ^b   Craig, Michael ^b   Jillella, Anand ^a   Hamadani, Mehdi ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; PLERIXAFOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; AGED; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; DRUG SAFETY; FEMALE; HUMAN; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; SALVAGE THERAPY; STEM CELL MOBILIZATION; TREATMENT FAILURE;

EID: 84861042264     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/931071     Document Type: Article

References (18)

1. Gertz M. A., Current status of stem cell mobilization: review British Journal of Haematology 2010 150 6 647 662
2. Cottler-Fox M. H., Lapidot T., Petit I., Kollet O., DiPersio J. F., Link D., Devine S., Stem cell mobilization Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2003 419 437
3. DiPersio J. F., Micallef I. N., Stiff P. J., Bolwell B. J., Maziarz R. T., Jacobsen E., Nademanee A., McCarty J., Bridger G., Calandra G., Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma Journal of Clinical Oncology 2009 27 28 4767 4773
4. DiPersio J. F., Stadtmauer E. A., Nademanee A., Micallef I. N. M., Stiff P. J., Kaufman J. L., Maziarz R. T., Hosing C., Frehauf S., Horwitz M., Cooper D., Bridger G., Calandra G., Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma Blood 2009 113 23 5720 5726
5. Gai B., Holt M., Nervi B., Kinetics of hematopoietic progenitor cell mobilization with cyclophosphamide or cyclophosphamide plus AMD3100 using a mouse model Blood 2005 106: 5217
6. Devine S. M., Vij R., Rettig M., Todt L., McGlauchlen K., Fisher N., Devine H., Link D. C., Calandra G., Bridger G., Westervelt P., Dipersio J. F., Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction Blood 2008 112 4 990 998
7. Flomenberg N., Comenzo R. L., Badel K., Calandra G., Plerixafor (Mozobil) alone to mobilize hematopoietic stem cells from multiple myeloma patients for autologous transplantation Biology of Blood and Marrow Transplantation 2010 16 5 695 700
8. Flomenberg N., Devine S. M., DiPersio J. F., Liesveld J. L., McCarty J. M., Rowley S. D., Vesole D. H., Badel K., Calandra G., The use of AMD3100 plus G-CSF (Pubitemid 41208607)
9. Milone G., Leotta S., Indelicato F., Mercurio S., Moschetti G., Di Raimondo F., Tornello A., Consoli U., Guido G., Giustolisi R., G-CSF Alone vs cyclophosphamide plus G-CSF in PBPC mobilization of patients with lymphoma: results depend on degree of previous pretreatment Bone Marrow Transplantation 2003 31 9 747 754 (Pubitemid 36656666)
10. Hosing C., Saliba R. M., Ahlawat S., Krbling M., Kebriaei P., Alousi A., De Lima M., Okoroji J. G., McMannis J., Qazilbash M., Anderlini P., Giralt S., Champlin R. E., Khouri I., Popat U., Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma American Journal of Hematology 2009 84 6 335 337
11. Watanabe H., Watanabe T., Suzuya H., Wakata Y., Kaneko M., Onishi T., Okamoto Y., Abe T., Kawano Y., Kagami S., Takaue Y., Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor Bone Marrow Transplantation 2006 37 7 661 668
12. D'Addio A., Curti A., Worel N., Douglas K., Motta M. R., Rizzi S., Dan E., Taioli S., Giudice V., Agis H., Kopetzky G., Soutar R., Casadei B., Baccarani M., Lemoli R. M., The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF Bone Marrow Transplantation 2011 46 3 356 363
13. Hbel K., Fresen M. M., Salwender H., Basara N., Beier R., Theurich S., Christopeit M., Bogner C., Galm O., Hartwig R., Heits F., Lordick F., Rsler W., Wehler D., Zander A. R., Albert M. H., Dressler S., Ebinger M., Frickhofen N., Hertenstein B., Kiehl M., Liebler S., von Lilienfeld-Toal M., Weidmann E., Weigelt C., Lange F., Krger N., Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program Bone Marrow Transplantation 2011 46 8 1045 1052
14. Jantunen E., Penttil K., Pyrl M., Mahlamki E., Kuittinen T., Nousiainen T., Addition of plerixafor to a chemotherapy plus G-CSF mobilization in hard-to-mobilize patients Bone Marrow Transplantation 2011 46 2 308 309
15. Jantunen E., Lemoli R. M., Preemptive use of plerixafor in difficult-to-mobilize patients: an emerging concept. Transfusion. In press
16. Calandra G., McCarty J., McGuirk J., Tricot G., Crocker S. A., Badel K., Grove B., Dye A., Bridger G., AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: Compassionate use data Bone Marrow Transplantation 2008 41 4 331 338 (Pubitemid 351330727)
17. Dugan M. J., Maziarz R. T., Bensinger W. I., Nademanee A., Liesveld J., Badel K., Dehner C., Gibney C., Bridger G., Calandra G., Safety and preliminary efficacy of plerixafor (mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization Bone Marrow Transplantation 2010 45 1 39 47
18. Shaughnessy P., Islas-Ohlmayer M., Murphy J., Hougham M., MacPherson J., Winkler K., Silva M., Steinberg M., Matous J., Selvey S., Maris M., McSweeney P. A., Cost and clinical analysis of autologous hematopoietic stem cell mobilization with G-CSF and plerixafor compared to G-CSF and cyclophosphamide Biology of Blood and Marrow Transplantation 2011 17 5 729 736